Back to DatabaseNot FDA Approved
LL-37
Also known as: Cathelicidin, hCAP-18 active fragment
Antimicrobial
Preclinical
LL-37 is the sole human cathelicidin antimicrobial peptide, serving as a critical component of innate immunity. It possesses broad-spectrum antimicrobial activity against bacteria, viruses, and fungi, while also functioning as an immune modulator, wound healer, and anti-biofilm agent.
Regulatory & Approval Status
LL-37 is not FDA-approved for human use. Although it has been studied in laboratory and preclinical settings for immune and wound-healing properties, there is no approved therapeutic product.
Information compiled from FDA compounding guidance and public regulatory sources. For research and educational purposes only; not medical advice.